Strategy (MSTR) stock slips with bitcoin as new filing details $108.8 million crypto buy
31 December 2025
1 min read

Strategy (MSTR) stock slips with bitcoin as new filing details $108.8 million crypto buy

NEW YORK, December 31, 2025, 12:28 ET — Regular session

Strategy Inc shares fell 1.8% to $152.88 in midday trading on Wednesday, tracking a more than 1% dip in bitcoin.

The software company — formerly MicroStrategy — has become a volatile bitcoin proxy because it holds the token on its balance sheet and regularly raises money to buy more. That structure is back in focus as investors weigh the trade-off between added bitcoin exposure and shareholder dilution. Strategy

A Form 8-K dated Dec. 29 showed Strategy bought 1,229 bitcoins for $108.8 million between Dec. 22 and Dec. 28 at an average price of about $88,568 per coin, funded by selling 663,450 shares through its at-the-market program. The filing put total holdings at 672,497 bitcoins and said roughly $11.7 billion of common stock remained available for sale under the program. SEC

At bitcoin’s latest price of about $87,516, that stash would be worth roughly $58.9 billion.

Other crypto-linked stocks were mixed: Coinbase fell 1.2% and Marathon Digital slipped 1.5%, while miner Riot Platforms rose 1.6%.

At-the-market offerings allow a company to sell newly issued shares into the market at prevailing prices, typically in small increments. For investors, the benefit is fresh capital to deploy quickly — and the cost is dilution as the share count rises.

Strategy traded between $152.53 and $157.48 on the day.

Chairman Michael Saylor posted “Back to Orange” on social media ahead of the disclosure, a phrase long associated by followers with fresh bitcoin buying. Barron’s

Traders are likely to keep keying off bitcoin’s direction into year-end trading and whether Strategy continues tapping equity markets for more purchases. The company is expected to report quarterly results in early February, according to Zacks’ earnings calendar. Zacks

For now, the stock’s day-to-day path remains tightly tied to bitcoin’s swings, with financing headlines adding another layer of volatility.

Stock Market Today

  • Northrop Grumman Shares Climb but DCF Valuation Suggests Overvaluation
    January 21, 2026, 4:58 PM EST. Northrop Grumman (NOC) has surged 143.5% over five years, with a recent share price of $657.30. Yet, its intrinsic value based on a Discounted Cash Flow (DCF) model is estimated at $539.46, implying the stock is about 21.8% overvalued. The DCF model projects future free cash flows growing from $3.33 billion in 2026 to $4.86 billion in 2035. Despite strong returns-32.6% in the past year-the stock's valuation score is moderate, reflecting concerns over potential premium pricing. Investors weigh these factors against Northrop Grumman's position as a leading U.S. defense contractor amid steady government spending. The current market price may already reflect expectations for continued contract gains and cash flow growth, leading to cautious outlook on further upside.
Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing
Previous Story

Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

Ondas Holdings (ONDS) stock jumps today after $10 million autonomous systems order haul
Next Story

Ondas Holdings (ONDS) stock jumps today after $10 million autonomous systems order haul

Go toTop